E3 Ubiquitin Ligases in Endothelial Dysfunction and Vascular Diseases: Roles and Potential Therapies

Yihan Wang1, Yixiong Zhan1,2, Linsiqi Wang1

  • 1National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China.

Insights

Ubiquitin E3 ligases regulate endothelial function and vascular integrity. Understanding their role in diseases like atherosclerosis and diabetes offers new therapeutic targets.

Area of Science:

  • Biochemistry and Molecular Biology
  • Vascular Biology
  • Immunology

Background:

  • Ubiquitin E3 ligases are crucial enzymes involved in protein ubiquitination, impacting cellular processes like immunity, cell death, and cancer.
  • Emerging research highlights the significant involvement of E3 ubiquitin ligases in the development of endothelial dysfunction and associated vascular pathologies.

Approach:

  • This review synthesizes recent findings on how E3 ubiquitin ligases modulate key aspects of endothelial cell function.
  • The review examines the mechanisms by which these ligases influence endothelial junctions, vascular integrity, activation, and apoptosis.
  • It also summarizes the roles and mechanisms of E3 ubiquitin ligases in various vascular diseases, including atherosclerosis, diabetes, hypertension, pulmonary hypertension, and acute lung injury.

Key Points:

  • E3 ubiquitin ligases are critical regulators of endothelial cell function, impacting vascular integrity and cellular processes.
  • Dysregulation of E3 ubiquitin ligases contributes to the pathogenesis of diverse vascular diseases.
  • Specific E3 ligases play distinct roles in endothelial activation, apoptosis, and maintenance of vascular homeostasis.

Conclusions:

  • E3 ubiquitin ligases represent a promising area for understanding and treating vascular diseases.
  • Targeting E3 ubiquitin ligases offers potential therapeutic strategies for conditions characterized by endothelial dysfunction.
  • Further research into the specific mechanisms of E3 ligases in vascular diseases is warranted for clinical translation.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
204
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K